Therapeutic targeting of 3′, 5′-cyclic nucleotide phosphodiesterases: inhibition and beyond
GS Baillie, GS Tejeda, MP Kelly - Nature reviews Drug discovery, 2019 - nature.com
Phosphodiesterases (PDEs), enzymes that degrade 3′, 5′-cyclic nucleotides, are being
pursued as therapeutic targets for several diseases, including those affecting the nervous …
pursued as therapeutic targets for several diseases, including those affecting the nervous …
[HTML][HTML] Genome interpretation using in silico predictors of variant impact
Estimating the effects of variants found in disease driver genes opens the door to
personalized therapeutic opportunities. Clinical associations and laboratory experiments …
personalized therapeutic opportunities. Clinical associations and laboratory experiments …
[HTML][HTML] Cannabinoids alleviate the LPS-induced cytokine storm via attenuating NLRP3 inflammasome signaling and TYK2-mediated STAT3 signaling pathways in …
SV Suryavanshi, M Zaiachuk, N Pryimak, I Kovalchuk… - Cells, 2022 - mdpi.com
Cannabinoids, mainly cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC), are the most
studied group of compounds obtained from Cannabis sativa because of their several …
studied group of compounds obtained from Cannabis sativa because of their several …
[HTML][HTML] An alzheimer's disease patient-derived olfactory stem cell model identifies gene expression changes associated with cognition
An early symptom of Alzheimer's disease (AD) is an impaired sense of smell, for which the
molecular basis remains elusive. Here, we generated human olfactory neurosphere-derived …
molecular basis remains elusive. Here, we generated human olfactory neurosphere-derived …
Resveratrol prevents ISO-induced myocardial remodeling associated with regulating polarization of macrophages through VEGF-B/AMPK/NF-kB pathway
Y Li, L Feng, G Li, J An, S Zhang, J Li, J Liu… - International …, 2020 - Elsevier
Macrophage expansion and inflammatory responses are involved in induction of cardiac
remodeling. Resveratrol has strong anti-inflammatory effects, however its effect on …
remodeling. Resveratrol has strong anti-inflammatory effects, however its effect on …
mAKAPβ signalosomes–a nodal regulator of gene transcription associated with pathological cardiac remodeling
K Dodge-Kafka, M Gildart, K Tokarski, MS Kapiloff - Cellular signalling, 2019 - Elsevier
Striated myocytes compose about half of the cells of the heart, while contributing the majority
of the heart's mass and volume. In response to increased demands for pumping power …
of the heart's mass and volume. In response to increased demands for pumping power …
[HTML][HTML] Dynamic Regulation of Cysteine Oxidation and Phosphorylation in Myocardial Ischemia–Reperfusion Injury
KM Casin, JW Calvert - Cells, 2021 - mdpi.com
Myocardial ischemia–reperfusion (I/R) injury significantly alters heart function following
infarct and increases the risk of heart failure. Many studies have sought to preserve …
infarct and increases the risk of heart failure. Many studies have sought to preserve …
Targeting cAMP signaling compartments in iPSC-derived models of cardiovascular disease
T Liu, E Klussmann - Current Opinion in Pharmacology, 2023 - Elsevier
Abstract Adenosine 3′, 5′-cyclic monophosphate (cAMP) acts as a second messenger
that is involved in the regulation of a plethora of processes. The activation of cAMP signaling …
that is involved in the regulation of a plethora of processes. The activation of cAMP signaling …
An Alzheimer's disease patient-derived olfactory cell model identifies gene expression changes associated with cognition
An early symptom of Alzheimer's disease (AD) is an impaired sense of smell, for which the
molecular basis remains elusive. Here, we generated human olfactory neurosphere-derived …
molecular basis remains elusive. Here, we generated human olfactory neurosphere-derived …
Form follows function: polymorphisms in mAKAP alter cardiac cAMP/PKA signaling
S Paruchuri, CK Thodeti - American Journal of Physiology …, 2018 - journals.physiology.org
Cardiovascular diseases (CVDs) are a leading cause of death in the United States and the
world. The global costs for CVDs is increasing at alarming rate with an expected $180 billion …
world. The global costs for CVDs is increasing at alarming rate with an expected $180 billion …